Jan O. Johansson founded Esperion Therapeutics, Inc. Presently, Dr. Johansson is Senior Vice President-Medical Affairs at Resverlogix Corp.

He is also on the board of Artery Therapeutics, Inc. and Member of American Heart Association, Inc. and Member of European Atherosclerosis Society.

In the past he held the position of Vice President-Clinical Affairs at Esperion Therapeutics, Inc., Vice President-Clinical, Research & Development at Lipid Sciences, Inc., Chief Medical Officer for Nuvelo, Inc. and Associate Professor at Karolinska University Hospital.

He received a doctorate from Karolinska Institutet.